NCT02788578View on ClinicalTrials.gov

A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours

TerminatedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Neuroendocrine Tumours
Trial Locations (12)

Unknown

Peter MacCallum Cancer Centre, East Melbourne

IUCT Oncopole, Toulouse

Institut Gustave Roussy, Villejuif

Zentralklinil Bad Berka, Bad Berka

Charité, Berlin

Klinikum rechts der Usar, München

Unversità degli Studi di Messina, Messina

IEO Institutio Europeo di Oncologia, Milan

Queen Elizabeth Hospital Birmingham, Birmingham

Kings College Hospital, London

Royal Free Hospital London, London

The Christie NHS Foundation Trust, Manchester

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY

NCT02788578 - A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours | Biotech Hunter | Biotech Hunter